JP2014152125A5 - - Google Patents

Download PDF

Info

Publication number
JP2014152125A5
JP2014152125A5 JP2013021411A JP2013021411A JP2014152125A5 JP 2014152125 A5 JP2014152125 A5 JP 2014152125A5 JP 2013021411 A JP2013021411 A JP 2013021411A JP 2013021411 A JP2013021411 A JP 2013021411A JP 2014152125 A5 JP2014152125 A5 JP 2014152125A5
Authority
JP
Japan
Prior art keywords
iga secretion
secretion promoter
iga
promoter according
food
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013021411A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014152125A (ja
JP6160011B2 (ja
Filing date
Publication date
Priority claimed from JP2013021411A external-priority patent/JP6160011B2/ja
Priority to JP2013021411A priority Critical patent/JP6160011B2/ja
Application filed filed Critical
Priority to KR1020130040848A priority patent/KR20140100380A/ko
Priority to TW102113294A priority patent/TWI598102B/zh
Priority to US13/871,517 priority patent/US20140220080A1/en
Publication of JP2014152125A publication Critical patent/JP2014152125A/ja
Publication of JP2014152125A5 publication Critical patent/JP2014152125A5/ja
Publication of JP6160011B2 publication Critical patent/JP6160011B2/ja
Application granted granted Critical
Priority to KR1020190048192A priority patent/KR101985644B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013021411A 2013-02-06 2013-02-06 ＩｇＡ分泌促進剤 Active JP6160011B2 (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2013021411A JP6160011B2 (ja) 2013-02-06 2013-02-06 ＩｇＡ分泌促進剤
KR1020130040848A KR20140100380A (ko) 2013-02-06 2013-04-15 IgA 분비 촉진제
TW102113294A TWI598102B (zh) 2013-02-06 2013-04-15 使用難消化性糊精在製備IgA分泌促進劑、黏膜免疫活化劑、抗感染症劑及抗過敏劑的用途
US13/871,517 US20140220080A1 (en) 2013-02-06 2013-04-26 IgA SECRETION PROMOTER
KR1020190048192A KR101985644B1 (ko) 2013-02-06 2019-04-25 면역 증진제 및 이를 포함하는 면역 개선용 음식품 조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013021411A JP6160011B2 (ja) 2013-02-06 2013-02-06 ＩｇＡ分泌促進剤

Publications (3)

Publication Number Publication Date
JP2014152125A JP2014152125A (ja) 2014-08-25
JP2014152125A5 true JP2014152125A5 (enExample) 2016-04-07
JP6160011B2 JP6160011B2 (ja) 2017-07-12

Family

ID=51259397

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013021411A Active JP6160011B2 (ja) 2013-02-06 2013-02-06 ＩｇＡ分泌促進剤

Country Status (4)

Country Link
US (1) US20140220080A1 (enExample)
JP (1) JP6160011B2 (enExample)
KR (2) KR20140100380A (enExample)
TW (1) TWI598102B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7359374B2 (ja) 2017-10-26 2023-10-11 株式会社ダイセル 腸管免疫亢進剤、食品、及び医薬

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04179459A (ja) * 1990-11-13 1992-06-26 Matsutani Kagaku Kogyo Kk 大腸癌予防作用を有する食品用又は飼料用組成物
JPH05178902A (ja) * 1991-10-29 1993-07-20 Matsutani Kagaku Kogyo Kk 難消化デキストリン
JP2003201239A (ja) 2001-11-05 2003-07-18 Meiji Milk Prod Co Ltd 免疫賦活食品組成物
KR100485154B1 (ko) * 2002-05-22 2005-04-22 주식회사 삼양제넥스 난소화성 덱스트린을 포함하는 면역활성 조성물
JP2005047829A (ja) * 2003-07-30 2005-02-24 Taiyo Kagaku Co Ltd 炎症性腸疾患の予防・治療剤
RU2388478C2 (ru) * 2003-10-24 2010-05-10 Н.В. Нютрисиа Иммуномодулирующие олигосахариды
JP4382465B2 (ja) 2003-12-16 2009-12-16 三井農林株式会社 粘膜免疫賦活剤
JP2005289847A (ja) * 2004-03-31 2005-10-20 Unitika Ltd 血糖値上昇抑制剤
EP1629727A1 (en) * 2004-08-24 2006-03-01 N.V. Nutricia Composition containing fermentable polysaccharides
ES2369789T3 (es) * 2005-04-21 2011-12-07 The Hokuren Federation Of Agricultural Cooperatives 1-kestosa para tratar alergias y dermatitis atópica.
JP5367228B2 (ja) * 2007-02-28 2013-12-11 公立大学法人大阪府立大学 腸管免疫賦活化剤及び抗アレルギー剤
JP2010254594A (ja) * 2009-04-22 2010-11-11 Fujifilm Corp 腸内バクテロイデス増殖促進剤
JP2011184300A (ja) * 2010-03-04 2011-09-22 Lotte Co Ltd イムノグロブリンａ分泌促進剤

Similar Documents

Publication Publication Date Title
JP2014129360A5 (enExample)
EP4249055A3 (en) Tofacitinib oral sustained release dosage forms
HUE060743T2 (hu) Gyógyszerészeti kompozíciók, amelyek tartalmaznak imidazothiadiazol- és imidazopiridazinszármazékokat mint proteáz aktívált receptor 4 (PAR4) inhibitorokat trombocitaaggregációk kezelésére
JP2014515597A5 (enExample)
PH12015502755A1 (en) Insulin glargine / lixisenatide fixed ratio formulation
WO2014121764A3 (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions
TN2014000322A1 (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
MX367210B (es) Soluciones orales estables para api combinados.
WO2014153009A3 (en) Thiosaccharide mucolytic agents
ZA202102039B (en) Pharmaceutical compositions comprising rpl554 in hfa-134a for administration by inhalation
WO2014137797A3 (en) Stable glucokinase activator compositions
WO2014203275A3 (en) An improved process for the preparation of apixaban and intermediates thereof
EP2682101A3 (en) Inhalation Compositions Comprising Glucose Anhydrous
WO2015001163A3 (es) Nanopartículas lipídicas para la cicatrización de heridas
WO2014007781A3 (en) Inhalation compositions
TN2015000267A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
EP2682100A3 (en) Inhalation Compositions Comprising Muscarinic Receptor Antagonist
EA201591415A1 (ru) Фармацевтические композиции, включающие многокомпонентные кристаллические частицы, подходящие для применения в ингаляционной терапии
EP2682129A3 (en) Compositions Comprising Muscarinic Receptor Antagonist and Glucose Anhydrous
CL2015002702A1 (es) Composiciones farmacéuticas micronizadas.
MX2017014776A (es) Combinacion farmaceutica de everolimus con dactolisib.
JP2014152125A5 (enExample)
MX355719B (es) Composicion farmaceutica en forma de una suspension oral que comprende una fraccion flavonoica y goma de xantano.
JP2017517574A5 (enExample)
JP2014101346A5 (enExample)